ClinicalTrials.Veeva

Menu

MR Radiomic Features in Prostate Cancer

S

San Donato Group (GSD)

Status

Completed

Conditions

Prostate Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

A combination of correct interpretation of imaging and biopsy has given promising results in terms of detecting clinically significant cancer at radical prostatectomy.

Full description

Quantitative approaches to medical image analysis have been developed in recent years with the aim to overcome the limitation of qualitative image interpretation, and provide biomarkers for disease characterization. In particular, the new paradigm, "radiomics", is emerging as the high-throughput extraction of quantitative features from imaging which can aid in characterizing phenotype as in vivo expression of tumoral genotype. The goal of radiomics is to extract accurate and reliable quantitative biomarkers which enhance diagnostic confidence in oncology. A combination of correct interpretation of imaging and biopsy has given promising results in terms of detecting clinically significant cancer at radical prostatectomy.

Enrollment

200 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • > 18 years of age
  • In house MRI with contrast medium
  • PCa (prostate cancer) biopsy proven diagnosis
  • In house radical prostatectomy

Exclusion criteria

  • < 18 years of age
  • MRI without contrast medium
  • Radical prostatectomy executed not in Institution

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems